Related Experiment Video
Updated: Dec 4, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
898
Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
Yiting Wang1,2, Hubing Shi3, Huan Meng4
1Institutes of Biomedical Sciences, Zhongshan-Xuhui Hospital, Key Laboratory of Epigenetics and Metabolism, Fudan University, Shanghai, China.
Frontiers in Pharmacology
|October 26, 2020
Abstract
No abstract available in PubMed .
Keywords:
CAR-T and CAR-NK cell-therapyacquired resistancecancer therapygene regulationimmune checkpointMore Related Videos
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.6K
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
6.0K